Ranbaxy appoints Dr Himadri Sen as Prez (R

Gurgaon, Mar 11: Pharma major Ranbaxy Laboratories Ltd todayannounced appoint ment of Dr Himadri Sen as its new President - R&D(Generics and NDDS).

Ranbaxy, Chief Executive Officer Malvinder Singh said,'' Dr Sen'sappointment adds significant weight to the substantial research anddevelopment effort currently underway at Ranbaxy.'' Dr Sen has workedwith leading Indian and global pharmaceutical companies in the areas ofpharmaceutical research, technology development and transfer, plantsupport activities and regulatory affairs.

He has been associated in various capacities with organisationslike the Manchester Area Health Authority, UK, the St Mary's Hospitaland International Development Laboratories, UK, Imperial ChemicalIndustries, UK, E R Squibb and Sons Ltd, UK, and Lupin and Ranbaxy Labs.

UNI >